| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |